SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: blue_chip who wrote (138)	3/14/2001 8:07:42 AM
From: Jim Oravetz	Read Replies (1) of 164

Oncolytics Biotech Inc. Reports Financial Results for 2000 Business Editors CALGARY, Alberta--(BUSINESS WIRE)--March 14, 2001--Oncolytics (TSE:ONC.) Oncolytics Biotech Inc. (TSE:ONC.) today reported its financial results for the year ended December 31, 2000. Total loss for the year ended December 31, 2000 was $3,613,152 or $0.22 per share compared to a loss of $574,462 or $0.10 per share for the previous year. The increase in losses from 1999 was primarily driven by increased research and development expenses associated with the commencement and continuation of Phase I human clinical trials, and milestone payments to the founding shareholders resulting from commitments under the original share purchase agreement. The Company reported $310,000 in Revenues for the year ended December 31, 2000 from a payment received for rights associated with a licensing agreement. No similar revenues were received in 1999. The Company also recorded interest income of $905,690 in 2000 ($2,909 in 1999) resulting from significantly higher cash and investment balances in the year. snip....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next